false
0001739174
0001739174
2026-09-01
2026-09-01
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
September 1, 2026
BIOMX INC.
(Exact name of registrant as specified in its charter)
| Delaware |
|
001-38762 |
|
82-3364020 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer
Identification No.) |
850 New Burton Road, Suite 201, Dover, Delaware
19904
(Address of principal executive offices, including
zip code)
(972) 52-437-4900
(Registrant’s telephone number, including
area code)
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, $0.0001 par value per share |
|
PHGE |
|
NYSE American |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
On September 1, 2026, BiomX Inc. (the “Company”)
announced that it will change its corporate name to Tessera Defense and Homeland Security Inc., effective at 12:01 a.m., Eastern Time,
on September 11, 2026 (the “Name Change”). On August 31, 2026, the Company’s Board of Directors approved the Name Change
and an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect it. Pursuant to Section 242(d)(1)
of the Delaware General Corporation Law, no stockholder approval is required. The Company expects to file a certificate of amendment with
the Secretary of State of the State of Delaware, to become effective at the time stated above.
In connection with the Name Change, the Company’s
common stock will begin trading on the NYSE American under the new ticker symbol “HLSQ” at the market open on September 11,
2026. The common stock will continue to trade under the symbol “PHGE” until that time. The Company’s common stock will
continue to be identified by CUSIP number 09090D 608, which will be assigned upon effectiveness of the Company’s previously announced
one-for-ten reverse stock split on September 9, 2026; CUSIP Global Services has confirmed that the CUSIP number will not change as a
result of the Name Change.
The Name Change does not affect the rights of
the Company’s stockholders. No action is required by stockholders, and no exchange of stock certificates or book-entry positions
is required. The Name Change and the reverse stock split are separate corporate actions.
The Company will report the filing of the certificate
of amendment under Item 5.03 of Form 8-K. A copy of the press release announcing the Name Change is attached as Exhibit 99.1 to this Current
Report and is incorporated herein by reference.
Forward-Looking Statements. This
Current Report contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities
Litigation Reform Act of 1995, including statements regarding the anticipated timing and effects of the name change, the ticker symbol
change and the reverse stock split. These statements are based on the Company’s current expectations and are subject to risks and
uncertainties that could cause actual results to differ materially, including the timing of the filing and effectiveness of the certificate
of amendment and the processing of the corporate actions by the NYSE American and DTC, as well as the risks described in the Company’s
filings with the Securities and Exchange Commission, including under “Risk Factors” in the Company’s Annual Report on
Form 10-K for the fiscal year ended December 31, 2025, as amended, and the Company’s Quarterly Report on Form 10-Q for the quarter
ended June 30, 2026. The Company undertakes no obligation to update any forward-looking statement except as required by law.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| 99.1 |
Press Release of BiomX Inc., dated September 1, 2026 |
| |
|
| 104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| BIOMX INC. |
|
| |
|
|
| Date: September 1, 2026 |
|
| |
|
|
| By: |
/s/ Michael Oster |
|
| Name: |
Michael Oster |
|
| Title: |
Chief Executive Officer |
|
Exhibit
99.1
BiomX
Inc. to Become Tessera Defense and Homeland Security Inc.
Name
change effective September 11, 2026; common stock to trade on the NYSE American under the new symbol “HLSQ”
NETANYA,
Israel, September 1, 2026 – BiomX Inc. (NYSE American: PHGE) (the “Company”) today announced that it will change
its corporate name to Tessera Defense and Homeland Security Inc., effective at 12:01 a.m., Eastern Time, on September 11, 2026. The Company’s
common stock will trade on the NYSE American under the new ticker symbol “HLSQ.”
The
new name completes the Company’s transformation into a defense and homeland security technology group, built through the acquisitions
and investments it has made over the past year.
A
tessera is a single tile in a mosaic. Alone it is a fragment; set alongside others, it becomes part of a complete picture. The name describes
how the Company is assembled: individual technology companies, each substantial in its own right, brought together into one architecture
for prediction, detection, analysis and response.
The
effective date was chosen deliberately. September 11 is the date that changed how the world understands security, and the day that gave
the term homeland security its modern meaning. In adopting the name on that date, the Company honors the memory of those who were lost
in 2001 and the first responders who went toward the danger, and dedicates itself to the work their loss demanded: seeing threats early,
understanding them quickly, and helping those who must act on them.
“We did not choose this date lightly, and we do not take it
lightly,” said Michael Oster, Chief Executive Officer of BiomX. “Twenty-five years ago, the failure was not one of courage.
It was a failure to connect what was already known. Everything we are building is aimed at that gap: technologies that predict, detect,
make sense of what they detect, and recommend a response. Tessera is the right name for that work, because no single piece of it matters
on its own. What matters is the picture they make together.”
The Company’s portfolio today includes
Dr. Frucht Systems Ltd., which develops threat detection technology; Zorro Net Ltd., which provides AI-powered prediction, analysis,
validation, coordination and response recommendation or initiation, and whose systems are deployed with defense and critical
infrastructure customers in Israel, including under a framework agreement with Israel Railways; and a minority interest in, and an
option to acquire, M.E.A. Testing Systems Ltd. (Motomea), which specializes in electric motor testing and validation for unmanned
and autonomous systems.
What
the Name Change Means for Stockholders
The
name change does not affect the rights of the Company’s stockholders. No action is required by stockholders, and no exchange of
book-entry positions or stock certificates is necessary. The Company’s common stock will be identified by CUSIP number 09090D 608.
The Company’s common stock will continue to trade under the symbol “PHGE” until the effective time of the name change.
As
previously announced on August 28, 2026, the Company will effect a one-for-ten reverse stock split of its common stock, which is expected
to become effective at 12:01 a.m., Eastern Time, on September 9, 2026, with the common stock beginning to trade on a split-adjusted basis
when the market opens on that date. The reverse stock split and the name change are separate corporate actions.
About
the Company
BiomX
Inc., to be renamed Tessera Defense and Homeland Security Inc., is a technology group focused on defense and homeland security. Through
its subsidiaries and investments, the Company develops and deploys threat detection, AI-powered analysis and related technologies for
defense, security and critical infrastructure customers. The Company’s common stock is listed on the NYSE American.
Forward-Looking
Statements
This
press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including
statements regarding the timing and effectiveness of the name change, the change of the Company’s ticker symbol, the reverse stock
split, and the Company’s strategy and portfolio. Forward-looking statements are based on management’s current expectations
and are subject to risks and uncertainties, including the risk that the name change or the reverse stock split does not become effective
when anticipated, and those risks described in the Company’s filings with the Securities and Exchange Commission, including its
Annual Report on Form 10-K and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026. Actual results may differ materially
from those expressed or implied. The Company undertakes no obligation to update any forward-looking statement, except as required by
law.
Media
Contact: Yair Ohayon, Yairo@biomx.com